Spark Investment Management LLC - CUMBERLAND PHARMACEUTICALS I ownership

CUMBERLAND PHARMACEUTICALS I's ticker is CPIX and the CUSIP is 230770109. A total of 48 filers reported holding CUMBERLAND PHARMACEUTICALS I in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Spark Investment Management LLC ownership history of CUMBERLAND PHARMACEUTICALS I
ValueSharesWeighting
Q3 2018$61,000
-7.6%
10,8000.0%0.00%
-25.0%
Q2 2018$66,000
-8.3%
10,8000.0%0.00%
-20.0%
Q1 2018$72,000
-25.8%
10,800
-18.2%
0.01%0.0%
Q4 2017$97,000
-7.6%
13,200
-11.4%
0.01%
-16.7%
Q3 2017$105,000
-26.1%
14,900
-26.6%
0.01%
-33.3%
Q2 2017$142,000
-9.0%
20,300
-10.2%
0.01%
-10.0%
Q1 2017$156,000
+25.8%
22,6000.0%0.01%0.0%
Q4 2016$124,000
+24.0%
22,600
+13.0%
0.01%
+25.0%
Q3 2016$100,000
-34.2%
20,000
-41.0%
0.01%
-42.9%
Q2 2016$152,000
-27.3%
33,900
-27.3%
0.01%
-33.3%
Q1 2016$209,000
-21.7%
46,600
-8.4%
0.02%
-38.2%
Q4 2015$267,000
+5.1%
50,900
+14.6%
0.03%
+3.0%
Q3 2015$254,000
-19.6%
44,4000.0%0.03%
-25.0%
Q2 2015$316,000
+7.1%
44,4000.0%0.04%
+7.3%
Q1 2015$295,000
+63.0%
44,400
+46.5%
0.04%
+36.7%
Q4 2014$181,000
+40.3%
30,300
+14.8%
0.03%
+57.9%
Q3 2014$129,000
+4.0%
26,400
-4.3%
0.02%
+5.6%
Q2 2014$124,000
-8.1%
27,600
-10.4%
0.02%
-14.3%
Q1 2014$135,000
+25.0%
30,800
+45.3%
0.02%
+10.5%
Q4 2013$108,000
+18.7%
21,200
+5.0%
0.02%
-9.5%
Q3 2013$91,000
-53.6%
20,200
-47.8%
0.02%
-59.6%
Q2 2013$196,00038,7000.05%
Other shareholders
CUMBERLAND PHARMACEUTICALS I shareholders Q1 2016
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 896,170$4,615,0003.22%
Ariel Investments 1,010,220$5,203,0000.06%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 183,000$942,0000.01%
Anfield Capital Management, LLC 4,530$23,0000.01%
Financial Gravity Asset Management, Inc. 2,000$10,0000.01%
Oakworth Capital, Inc. 3,052$16,0000.00%
BAILARD, INC. 11,816$61,0000.00%
DIMENSIONAL FUND ADVISORS LP 860,319$4,431,0000.00%
Renaissance Technologies 469,338$2,417,0000.00%
ACADIAN ASSET MANAGEMENT LLC 98,192$506,0000.00%
View complete list of CUMBERLAND PHARMACEUTICALS I shareholders